Drugmakers Now ‘Masters’ At Rolling Out Their Own Generics To Stifle Competition
(By Jay Hancock and Sydney Lupkin for Kaiser Health News) When PDL BioPharma’s $40 million blood-pressure medicine faced the threat
Read More(By Jay Hancock and Sydney Lupkin for Kaiser Health News) When PDL BioPharma’s $40 million blood-pressure medicine faced the threat
Read MoreThe affordability of prescription drugs is a pressing concern for many Americans, with broad agreement across the political spectrum that
Read More(By Kate Sheridan for STAT) Health economists walk a precarious tightrope: Their analyses are quantitative and, presumably, emotion-free. But health
Read More(By Shefali Luthra for Kaiser Health News) Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than
Read More(By Barclay E. Berdan, Scott Reiner, and Terry Shaw for STAT) Drug shortages are a major challenge for hospitals. Today, 121
Read More(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada
Read MoreIn a new report from the Government Accountability Office found the Medicare Plan Finder website is difficult to navigate and
Read MoreAccording to the California attorney general’s office, two pharmaceutical companies will pay the state of California a total of nearly
Read More(By Emmarie Huetteman for Kaiser Health News) The fight between policymakers intent on lowering prescription drug prices and the drugmakers
Read More(By Blake Farmer, Nashville Public Radio for Kaiser Health News) In a former church parsonage in Grundy County, Tenn., Karen
Read More